Gritstone Oncology Inc buy B. Riley
Start price
24.05.24
/
50%
€0.74
Target price
24.05.25
€2.76
Performance (%)
-14.05%
Price
23.07.24
€0.64
Summary
This prediction is currently active. The prediction for Gritstone Oncology Inc disappoints with a performance of -14.05%. This prediction currently runs until 24.05.25. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Gritstone Oncology Inc | -1.852% | -1.852% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by B__Riley for this prediction
In the thread Gritstone Oncology Inc diskutieren
Gritstone bio, Inc. (NASDAQ: GRTS) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $3.00 price target on the stock, down previously from $6.00.
Ratings data for GRTS provided by MarketBeat
Stopped prediction by B__Riley for Gritstone Oncology Inc
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€2.30
28.03.23
28.03.23
€7.38
28.03.24
28.03.24
-31.49%
29.03.24
29.03.24